These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 36618350)

  • 21. Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment.
    Adhikari S; Guha D; Mohan C; Mukherjee S; Tyler JK; Das C
    Subcell Biochem; 2022; 100():3-65. PubMed ID: 36301490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis.
    Cheung AH; Hui CH; Wong KY; Liu X; Chen B; Kang W; To KF
    Int J Cancer; 2023 Apr; 152(8):1510-1525. PubMed ID: 36093588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linking metabolic reprogramming to therapy resistance in cancer.
    Morandi A; Indraccolo S
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):1-6. PubMed ID: 28065746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic dependencies and targets in ovarian cancer.
    Zhang Y; Wang Y; Zhao G; Orsulic S; Matei D
    Pharmacol Ther; 2023 May; 245():108413. PubMed ID: 37059310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer.
    Wang G; Wang JJ; Guan R; Sun Y; Shi F; Gao J; Fu XL
    Curr Cancer Drug Targets; 2019; 19(7):534-550. PubMed ID: 30360743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting glucose metabolism for cancer therapy.
    Hamanaka RB; Chandel NS
    J Exp Med; 2012 Feb; 209(2):211-5. PubMed ID: 22330683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
    Tyszka-Czochara M; Konieczny P; Majka M
    J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
    Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
    Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.
    Guido C; Whitaker-Menezes D; Lin Z; Pestell RG; Howell A; Zimmers TA; Casimiro MC; Aquila S; Ando' S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2012 Aug; 3(8):798-810. PubMed ID: 22878233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
    Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
    BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy.
    Sun NY; Yang MH
    Front Oncol; 2020; 10():792. PubMed ID: 32509584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic targeting of cancers: from molecular mechanisms to therapeutic strategies.
    Sheng H; Niu B; Sun H
    Curr Med Chem; 2009; 16(13):1561-87. PubMed ID: 19442134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic alterations of cancer cells.
    Sciacovelli M; Gaude E; Hilvo M; Frezza C
    Methods Enzymol; 2014; 542():1-23. PubMed ID: 24862258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metabolic reprogramming in cancer: the art of balance].
    Yi M; Xiang B; Li X; Li G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 38(11):1177-87. PubMed ID: 24316928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic deregulation in prostate cancer.
    Srihari S; Kwong R; Tran K; Simpson R; Tattam P; Smith E
    Mol Omics; 2018 Oct; 14(5):320-329. PubMed ID: 30215656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic implication of tumor:stroma crosstalk in breast cancer.
    Morandi A; Chiarugi P
    J Mol Med (Berl); 2014 Feb; 92(2):117-26. PubMed ID: 24458539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic crosstalk in the breast cancer microenvironment.
    Dias AS; Almeida CR; Helguero LA; Duarte IF
    Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
    Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting prostate cancer metabolism: From metabolites to disease and therapy.
    Cardoso HJ; Carvalho TMA; Fonseca LRS; Figueira MI; Vaz CV; Socorro S
    Med Res Rev; 2021 May; 41(3):1499-1538. PubMed ID: 33274768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.